BDBM449090 US10702498, Compound 11::US11484525, Compound 11

SMILES C[NH+](C)[C@@H](CNC(=O)NC[C@@H](O)c1cnn(C)c1)Cc1ccccc1

InChI Key InChIKey=ARHYRFLVSNGIIR-IAGOWNOFSA-O

Data  4 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 449090   

TargetMu-type opioid receptor(Homo sapiens (Human))
The Regents Of The University Of California

US Patent
LigandPNGBDBM449090(US10702498, Compound 11 | US11484525, Compound 11)
Affinity DataKi:  1.86E+3nMAssay Description:Each compound was initially tested at 20 μM and was incubated with 3H-DPN at a concentration equal to the Kd (0.4 nM) of the radioligand in _...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
The Regents Of The University Of California

US Patent
LigandPNGBDBM449090(US10702498, Compound 11 | US11484525, Compound 11)
Affinity DataKi:  1.86E+3nMAssay Description:For a primary screen of selected molecules, binding to μOR was assessed by measuring competition against the radioligand 3H-diprenorphine (3H-DPN). ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
The Regents Of The University Of California

US Patent
LigandPNGBDBM449090(US10702498, Compound 11 | US11484525, Compound 11)
Affinity DataKi: <5.00E+4nMAssay Description:Each compound was initially tested at 20 μM and was incubated with 3H-DPN at a concentration equal to the Kd (0.4 nM) of the radioligand in _...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
The Regents Of The University Of California

US Patent
LigandPNGBDBM449090(US10702498, Compound 11 | US11484525, Compound 11)
Affinity DataKi: <5.00E+4nMAssay Description:For a primary screen of selected molecules, binding to μOR was assessed by measuring competition against the radioligand 3H-diprenorphine (3H-DPN). ...More data for this Ligand-Target Pair
In DepthDetails US Patent